JPRN-UMIN000008677已完成未知
Efficacy and Safety of treatment with Levofloxacin for Community-acquired Pneumonia - Levofloxacin Therapy for Community-acquired Pneumonia
Second Division, Department of Internal Medicine, Hamamatsu university school of medicine0 个研究点目标入组 300 人开始时间: 2012年8月14日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 300
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1.Patients who took respiratory quinolones for current pneumonia. 2.Patients who are prohibited to take levofloxacin. 3.Patients with liver dysfunction AST:more than three times the upper limit of normal ALT:more than three times the upper limit of normal T-bil:more than three times the upper limit of normal 4.Patients witg renal dysfunction (Cre is over than 3.0mg/dl, or Ccr is less than 30 mL/min/1.73m2) 5.Patients who has disease of central nervous system and expected spasm. 6.Patient whom conducting of the examination doctor judged inappropriate.
研究者
相似试验
已完成
不适用
Comparison of efficacy and safety of levofloxacin-containing versus standard sequential therapy in eradication of Helicobacter pylori infection in KoreaHelicobacter pylori infectionJPRN-UMIN000015375Severance Hospital, Yonsei University200
招募中
不适用
Comparison of Levofloxacin/Colistin with Levofloxacin/high dose Ampicillin-sulbactam infusion in treatment of Ventilator-Associated Pneumonia due to multi drug resistant AcinetobacterIRCT20120703010178N15Shahid Beheshti University of Medical Sciences56
已完成
不适用
Efficacy and safety of levofloxacin infusion in patients with NHCAP categorized as group B or C according to the JRS Guidelines for the Management of Hospital-Acquired Pneumonia in AdultsJPRN-UMIN000011837Department of Respiratory Medicine,University of Occupational and Environmental Health, Japan60
招募中
3 期
The effectiveness of levofloxacin in prevention of febrile episodes in non-Hodgkin lymphoma patients receiving R-CHOPFebrile episode in non-Hodgkin lymphomaFebrile episodeLevofloxacinR-CHOPNon-Hodgkin lymphomaTCTR20230719005Ratchadapisek Research Funds72
招募中
4 期
Pharmacokinetic study and safety of levofloxacin in pediatric tuberculosis treatmentMulti-drug resistant tuberculosisIsoniazid resistant tuberculosispatient with toxicity from the first line antituberculosisMDR-Hr-Toxicity from the first line anti-LevofloxacinTBTCTR20190515001Center of Excellence for Pediatric Infectious Diseases and Vaccines20